Published in J Clin Oncol on August 17, 2009
Biological, psychological and social processes that explain celebrities' influence on patients' health-related behaviors. Arch Public Health (2015) 0.90
Research Battles: Survival Tips From a Veteran. Integr Med (Encinitas) (2015) 0.75
Conventional and complementary therapies: a tale of two research standards? J Clin Oncol (2010) 0.75
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2007) 25.52
Estimating causal effects from large data sets using propensity scores. Ann Intern Med (1997) 19.65
Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med (2000) 19.56
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med (1994) 16.96
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol (2005) 5.82
Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J Clin Oncol (2003) 4.56
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res (2002) 3.09
The bias due to incomplete matching. Biometrics (1985) 2.90
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res (2002) 2.56
Evaluation of new treatments in radiation oncology: are they better than standard treatments? JAMA (2005) 2.37
Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst (2002) 1.77
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
Metastatic pancreatic cancer 2008: is the glass less empty? Oncologist (2008) 1.70
Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47
Penicillin: its discovery and early development. Semin Pediatr Infect Dis (2004) 1.32
Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med (2007) 1.27
Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol (2000) 1.20
Recent updates on the role of chemotherapy in pancreatic cancer. Semin Oncol (2005) 1.18
Complementary and alternative medicine in breast cancer patients. Palliat Support Care (2003) 1.17
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis. Cancer Chemother Pharmacol (2007) 1.16
A review of systemic therapy for advanced pancreatic cancer. Clin Adv Hematol Oncol (2003) 1.08
Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol (2000) 1.03
Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer (1999) 0.99
The case for randomized trials in cancer treatment: new is not always better. JAMA (2005) 0.90
Assessing observational studies of medical treatments. Emerg Themes Epidemiol (2005) 0.88
Chinese herbal medicine for cancer pain. Integr Cancer Ther (2007) 0.87
Treatment of metastatic pancreatic cancer. J Natl Compr Canc Netw (2005) 0.87
The response of acute leukemia to the administration of the folic acid antagonists, aminopterin and a-methopterin; report of 14 cases. Ann Intern Med (1950) 0.86
Complementary and alternative medicine: the role of the cancer center. J Clin Oncol (2001) 0.81
Management of liver metastases: new horizons for biologically based therapy. J Surg Res (2004) 0.81
Critical appraisal of clinical studies in Chinese herbal medicine. Zhong Xi Yi Jie He Xue Bao (2006) 0.79
The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX. Surg Oncol Clin N Am (2004) 0.79
Assessing observational studies of spinal fusion and chemonucleolysis. Spine (Phila Pa 1976) (2003) 0.78
Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med (2008) 6.80
Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med (2007) 6.61
Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect (2003) 5.66
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71
Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol (2005) 3.02
First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer (2010) 2.74
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA (2010) 2.67
Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect (2006) 2.63
International studies of prenatal exposure to polycyclic aromatic hydrocarbons and fetal growth. Environ Health Perspect (2006) 2.44
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer (2006) 2.36
Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study. Control Clin Trials (2004) 2.36
Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis (2005) 2.32
Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa. Cancer Epidemiol Biomarkers Prev (2008) 2.29
Facilitating cancer research using natural language processing of pathology reports. Stud Health Technol Inform (2004) 2.28
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat (2006) 2.26
Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol (2006) 2.26
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol (2005) 2.11
Pancreatic cancer and thromboembolic disease. Lancet Oncol (2004) 2.10
Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol (2007) 2.09
Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. Lancet Infect Dis (2012) 2.05
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol (2011) 2.00
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol (2002) 1.93
Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res (2010) 1.92
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys (2006) 1.77
Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis (2010) 1.70
Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst (2003) 1.68
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol (2002) 1.68
Molecular evidence of an interaction between prenatal environmental exposures and birth outcomes in a multiethnic population. Environ Health Perspect (2004) 1.66
The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J (2012) 1.64
High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS One (2007) 1.62
Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J Immunol (2007) 1.61
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med (2006) 1.57
Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst (2010) 1.50
Language matters: "sometimes we withdraw treatment but we never withdraw care". J Palliat Med (2007) 1.45
The effects of low-dose fentanyl on emergence agitation and quality of life in patients with moderate developmental disabilities. J Clin Anesth (2005) 1.44
Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. J Clin Oncol (2008) 1.44
Effect of reinforced laryngeal mask airway or endotracheal intubation anesthesia on adverse events: quality of life issues for dental patients requiring general sedation. Spec Care Dentist (2005) 1.39
Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. AIDS (2010) 1.36
Prolonged breast-feeding and mortality up to two years post-partum among HIV-positive women in Zambia. AIDS (2005) 1.36
Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol (2002) 1.34
Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease. PLoS One (2009) 1.25
Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst (2008) 1.22
Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev (2009) 1.21
Sharing and archiving nucleic acid structure mapping data. RNA (2011) 1.20
Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer. Cancer (2007) 1.19
Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys (2007) 1.17
Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis (2002) 1.16
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery (2011) 1.14
Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell Rep (2012) 1.14
Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas. Cancer (2008) 1.13
Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children. Clin Infect Dis (2011) 1.10
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat (2013) 1.10
Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst (2013) 1.09
Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer (2002) 1.08
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site. Oncogene (2003) 1.06
Ikaros silences T-bet expression and interferon-gamma production during T helper 2 differentiation. J Biol Chem (2009) 1.05
Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol Biomarkers Prev (2005) 1.05
Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study. Carcinogenesis (2012) 1.04
Arsenic exposure and anemia in Bangladesh: a population-based study. J Occup Environ Med (2008) 1.04
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships. J Med Chem (2011) 1.03
Pan-genomic analysis provides insights into the genomic variation and evolution of Salmonella Paratyphi A. PLoS One (2012) 1.00
Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. Cancer Res (2003) 1.00
Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat (2012) 0.99
Racial disparities in treatment and survival of male breast cancer. J Clin Oncol (2007) 0.98
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor. Pituitary (2011) 0.98
Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol (2004) 0.98
Foxp3 processing by proprotein convertases and control of regulatory T cell function. J Biol Chem (2008) 0.97
Foxp3 protein stability is regulated by cyclin-dependent kinase 2. J Biol Chem (2013) 0.95
Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis (2006) 0.93
Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa. BMC Med (2010) 0.93
Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma. Cancer (2006) 0.93
Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis (2008) 0.93
FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression. J Immunol (2009) 0.93
Low p53 binding protein 1 (53BP1) expression is associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys (2012) 0.93
A novel stereo-selective sulfonylurea, 1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one, has antitumor efficacy in in vitro and in vivo tumor models. Biochem Pharmacol (2002) 0.92
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits. Int J Surg Oncol (2012) 0.92
Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas. Proc Natl Acad Sci U S A (2007) 0.91
Head and neck squamous cell carcinoma in FAMMM syndrome. Head Neck (2009) 0.91
Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival. J Gastrointest Surg (2007) 0.91
The case for randomized trials in cancer treatment: new is not always better. JAMA (2005) 0.90
Breast cancer-related preferences among women with and without BRCA mutations. Breast Cancer Res Treat (2009) 0.90
NMR solution structure of a peptide from the mdm-2 binding domain of the p53 protein that is selectively cytotoxic to cancer cells. Biochemistry (2004) 0.90
Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway. Mol Cancer Ther (2005) 0.89
Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas. Pancreas (2008) 0.89
Cardiovascular risk and memory in non-demented elderly women. Neurobiol Aging (2008) 0.89
Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissue. J Neurooncol (2007) 0.89
The intensity and frequency of moral distress among different healthcare disciplines. J Clin Ethics (2013) 0.89
Acceptance and compliance with postpartum human papillomavirus vaccination. Obstet Gynecol (2012) 0.88
Intraoperative fluid administration is associated with perioperative outcomes in pancreaticoduodenectomy: a single center retrospective analysis. J Surg Oncol (2013) 0.88
Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Cancer Lett (2007) 0.88
Cyclophilin A from Schistosoma japonicum promotes a Th2 response in mice. Parasit Vectors (2013) 0.88
Cost savings from palliative care teams and guidance for a financially viable palliative care program. Health Serv Res (2014) 0.88
Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide. Mol Cancer Ther (2006) 0.86
Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review. Integr Cancer Ther (2005) 0.86
Use and benefits of laparoscopic hysterectomy for stage I endometrial cancer among medicare beneficiaries. J Oncol Pract (2012) 0.86